Serena Corsetti
-
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 2
- PARP inhibition in cancer therapy 2
-
- Breast Cancer Treatment Studies 5
-
- Chronic Lymphocytic Leukemia Research 3
-
- Advanced Breast Cancer Therapies 6
-
- Endometrial and Cervical Cancer Treatments 2
- Co-authors
- Michele BartolettiSara GagnoGiuseppe ToffoliRossana RoncatoMarcella MonticoBianca PosoccoFabio PuglisiDomenico Sergi
- Cited by
- OncologyDermatologyCancer Research
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Serena Corsetti
15 papers receiving 108 citations
Peers
Comparison fields: 5 of 37
- Oncology 55
- Dermatology 15
- Cancer Research 25
- Genetics 17
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Serena Corsetti
This map shows the geographic impact of Serena Corsetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Corsetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Corsetti more than expected).
Fields of papers citing papers by Serena Corsetti
This network shows the impact of papers produced by Serena Corsetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Corsetti. The network helps show where Serena Corsetti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Serena Corsetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 18 | |
| 10 | 2022 | 2 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 0 | |
| 13 | 2019 | 15 | |
| 14 | 2019 | 1 | |
| 15 | Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment. | 2009 | 7 |
| 16 | [Adjuvant chemotherapy in hormone-receptor positive HER2-negative early breast cancer]. | 2009 | 2 |
| 17 | Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients. | 2009 | 4 |
| 18 | Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines. | 2009 | 7 |
| 19 | 2008 | 11 |
About Serena Corsetti
Serena Corsetti is a scholar working on Oncology, Cancer Research and Genetics, having authored 19 papers that have together received 112 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), Cancer-related Molecular Pathways (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Oncology (55 citations), Dermatology (15 citations) and Cancer Research (25 citations). Serena Corsetti has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Michele Bartoletti, Sara Gagno, Giuseppe Toffoli, Rossana Roncato, Marcella Montico, Bianca Posocco, Fabio Puglisi, Domenico Sergi, Dario Didona and Giovanni Paolino.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.